These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9588385)

  • 1. Severe gastrointestinal dysfunction and retention of extended release nifedipine tablets.
    Smitz S; Bonnet V; Delporte JP
    J Am Geriatr Soc; 1998 May; 46(5):656-7. PubMed ID: 9588385
    [No Abstract]   [Full Text] [Related]  

  • 2. Bezoar formed by fragments of extended-release nifedipine tablets.
    Shepherd MF
    Clin Pharm; 1993 Nov; 12(11):849-52. PubMed ID: 8275650
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine GITS (gastrointestinal therapeutic system) bezoar.
    Prisant LM; Carr AA; Bottini PB; Kaesemeyer WH
    Arch Intern Med; 1991 Sep; 151(9):1868-9. PubMed ID: 1888255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic medication bezoar from extended-release nifedipine and procainamide.
    Reid T; Rubins JB; Levine J; DeCelles J; Silvis S
    Arch Fam Med; 1995 Aug; 4(8):715-7. PubMed ID: 7620602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-release nifedipine bezoar identified one year after discontinuation.
    Niezabitowski LM; Nguyen BN; Gums JG
    Ann Pharmacother; 2000; 34(7-8):862-4. PubMed ID: 10928396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacobezoar in a patient operated on for pyloric stenosis].
    Marín Pozo JF; Soriano Martínez M; Caba Porras I; Rodríguez Torné G; Castelo Luque A
    Farm Hosp; 2004; 28(1):59-63. PubMed ID: 15012180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special feature: picture of the month. Ingestion of nifedipine sustained-release tablets.
    Kreiling KM; Hampers LC; Baum CR
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1161-2. PubMed ID: 11074860
    [No Abstract]   [Full Text] [Related]  

  • 8. Retention of extended release nifedipine capsules in a patient with enteric stricture causing recurrent small bowel obstruction.
    Yeen WC; Willis IH
    South Med J; 2005 Aug; 98(8):839-42. PubMed ID: 16144187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of nifedipine extended release tabs in a patient with a colonic stricture.
    Georgopoulos S; Gerdes H
    Am J Gastroenterol; 1995 Dec; 90(12):2224-6. PubMed ID: 8540522
    [No Abstract]   [Full Text] [Related]  

  • 10. Tongue Edema Caused by Taking Nifedipine Controlled-Release Tablets.
    Zhang W; Xing W; Ling L
    Neurol India; 2024 Jan; 72(1):195. PubMed ID: 38443037
    [No Abstract]   [Full Text] [Related]  

  • 11. [A rare case of nifedipine bezoar].
    Jarry J; Sassoust G
    Presse Med; 2008 Mar; 37(3 Pt 1):428-30. PubMed ID: 18164899
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased risk in esophageal obstruction with slow-release medications.
    Simko V; Joseph D; Michael S
    J Assoc Acad Minor Phys; 1997; 8(2):38-42. PubMed ID: 9167415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.
    Wells CD; Luckritz TC; Rady MY; Zornik JM; Leighton JA; Patel BM
    Pharmacotherapy; 2006 Dec; 26(12):1802-5. PubMed ID: 17125441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced proteinuria after cessation of long-acting, osmotic release nifedipine GITS in diabetic nephropathy.
    Hess B
    Nephrol Dial Transplant; 1997 Aug; 12(8):1772-3. PubMed ID: 9269678
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.
    Saano V; Raatikainen O; Paronen P; Komulainen H
    Int J Clin Pharmacol Res; 1989; 9(4):247-54. PubMed ID: 2777428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
    ter Laak MA; Roos C; Touw DJ; van Hattum PR; Kwee A; Lotgering FK; Mol BW; van Pampus MG; Porath MM; Spaanderman ME; van der Post JA; Papatsonis DN; van 't Veer NE
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):84-91. PubMed ID: 25407260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bezoars of the stomach (author's transl)].
    Klasa M
    Przegl Lek; 1979; 36(7):577-9. PubMed ID: 388533
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacobezoar: an evolving new entity.
    Stack PE; Thomas E
    Dig Dis; 1995; 13(6):356-64. PubMed ID: 8590522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.